Literature DB >> 20071996

The electrodiagnostic characteristics of Glycogen Storage Disease Type III.

Lisa D Hobson-Webb1, Stephanie L Austin, Deeksha S Bali, Priya S Kishnani.   

Abstract

PURPOSE: Glycogen Storage Disease Type III, also known as debrancher deficiency or Cori disease, is an autosomal recessive disorder recognized for both its hepatic and muscle manifestations. The neuromuscular manifestations of Glycogen Storage Disease Type III are not well characterized. In this study, we attempt to better define the disorder.
METHODS: The medical records of 40 patients with Glycogen Storage Disease Type III seen at Duke University during 1990-2009 were reviewed. The medical records of all patients with nerve conduction studies and/or electromyography were examined.
RESULTS: Twelve patients with Glycogen Storage Disease Type III (aged 5-55 years) had undergone nerve conduction studies +/- electromyography. Three of these cases are presented in detail. Nine patients had Glycogen Storage Disease Type IIIa, two patients had Glycogen Storage Disease Type IIIb, and the clinical subtype of one patient was unknown. All had nerve conduction studies and of those nerves tested, abnormalities in the median motor response were most common, corresponding to previously described, intrinsic hand muscle weakness. Electromyography was performed in eight patients and myopathic findings were present in six individuals. Abnormal electrodiagnostic findings were more common in older patients. The two patients with Glycogen Storage Disease Type IIIb had electrodiagnostic evidence of nerve involvement with minor myopathic findings.
CONCLUSIONS: The neuromuscular manifestations of Glycogen Storage Disease Type III include myopathy and neuropathy and are more likely to occur with increasing age, even in those diagnosed with Glycogen Storage Disease Type IIIb. Intrinsic hand muscle weakness is likely due to a combination of nerve and muscle dysfunction, a finding that may have implications for treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20071996     DOI: 10.1097/GIM.0b013e3181cd735b

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  9 in total

1.  Mutation Analysis in Glycogen Storage Disease Type III Patients in the Netherlands: Novel Genotype-Phenotype Relationships and Five Novel Mutations in the AGL Gene.

Authors:  Christiaan P Sentner; Yvonne J Vos; Klary N Niezen-Koning; Bart Mol; G Peter A Smit
Journal:  JIMD Rep       Date:  2012-03-16

2.  Skeletal and cardiac muscle involvement in children with glycogen storage disease type III.

Authors:  Engy A Mogahed; Marian Y Girgis; Rodina Sobhy; Hala Elhabashy; Osama M Abdelaziz; Hanaa El-Karaksy
Journal:  Eur J Pediatr       Date:  2015-05-07       Impact factor: 3.183

Review 3.  Physical therapy assessment and whole-body magnetic resonance imaging findings in children with glycogen storage disease type IIIa: A clinical study and review of the literature.

Authors:  Anna Paschall; Aleena A Khan; Syed Faaiz Enam; Tracy Boggs; Ghada Hijazi; Michael Bowling; Stephanie Austin; Laura E Case; Priya Kishnani
Journal:  Mol Genet Metab       Date:  2021-10-09       Impact factor: 4.797

4.  A study of glycogen storage disease with 99Tcm-MIBI gated myocardial perfusion imaging.

Authors:  L G Wei; J Q Gao; X M Liu; J M Huang; X Z Li
Journal:  Ir J Med Sci       Date:  2013-04-25       Impact factor: 1.568

5.  Natural Progression of Canine Glycogen Storage Disease Type IIIa.

Authors:  Elizabeth D Brooks; Haiqing Yi; Stephanie L Austin; Beth L Thurberg; Sarah P Young; John C Fyfe; Priya S Kishnani; Baodong Sun
Journal:  Comp Med       Date:  2016-02       Impact factor: 0.982

6.  A novel homozygous splicing mutation of the AGL gene in a Chinese patient with severe myopathy involvement of glycogen storage disease type IIIa.

Authors:  Ying Li; Xueliang Qi; Wei Zhang; Liqun Feng; Yun Yuan
Journal:  Neurol Sci       Date:  2020-11-11       Impact factor: 3.307

7.  Characterization of a canine model of glycogen storage disease type IIIa.

Authors:  Haiqing Yi; Beth L Thurberg; Sarah Curtis; Stephanie Austin; John Fyfe; Dwight D Koeberl; Priya S Kishnani; Baodong Sun
Journal:  Dis Model Mech       Date:  2012-06-26       Impact factor: 5.758

8.  Molecular Diagnosis of Panel-Based Next-Generation Sequencing Approach and Clinical Symptoms in Patients With Glycogen Storage Disease: A Single Center Retrospective Study.

Authors:  Shen Ying; Zhang Zhihua; Zheng Yucan; Jin Yu; Lin Qian; Zheng Bixia; Cheng Weixia; Liu Zhifeng
Journal:  Front Pediatr       Date:  2020-12-03       Impact factor: 3.418

9.  Aerobic capacity and skeletal muscle characteristics in glycogen storage disease IIIa: an observational study.

Authors:  Philip J Hennis; Elaine Murphy; Rick I Meijer; Robin H Lachmann; Radha Ramachandran; Claire Bordoli; Gurinder Rayat; David J Tomlinson
Journal:  Orphanet J Rare Dis       Date:  2022-01-31       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.